Literature DB >> 2475060

Proteinuria and haematuria as predictors of schistosomiasis in children.

O O Kassim1.   

Abstract

Examination of urine samples from 922 children from Epe and surrounding communities in south-western Nigeria indicated a 13% prevalence of Schistosoma haematobium infection. Children, 10-14 years of age, accounted for 65% of the disease prevalence. Approximately 79% of the study population was negative for proteinuria, while 52.6% of children with 30 mg% proteinuria were positive for S. haematobium infection. However, 96% and 100% of all children who, respectively, had 30 mg% and 100 mg% proteinuria, in addition to haematuria, were found to be positive for the schistosome infection. This finding indicates that the use of haematuria and proteinuria as a combined diagnostic index significantly increased the sensitivity and specificity of the individual tests. Bacteriuria was found in 8.5% of infected children, compared with 5.2% of the control group. Streptococcus faecalis and E. coli were the two bacteria isolated from the urine specimens.

Entities:  

Mesh:

Year:  1989        PMID: 2475060     DOI: 10.1080/02724936.1989.11748620

Source DB:  PubMed          Journal:  Ann Trop Paediatr        ISSN: 0272-4936


  3 in total

Review 1.  Circulating antigen tests and urine reagent strips for diagnosis of active schistosomiasis in endemic areas.

Authors:  Eleanor A Ochodo; Gowri Gopalakrishna; Bea Spek; Johannes B Reitsma; Lisette van Lieshout; Katja Polman; Poppy Lamberton; Patrick M M Bossuyt; Mariska M G Leeflang
Journal:  Cochrane Database Syst Rev       Date:  2015-03-11

Review 2.  Relationship between schistosomiasis and bladder cancer.

Authors:  M H Mostafa; S A Sheweita; P J O'Connor
Journal:  Clin Microbiol Rev       Date:  1999-01       Impact factor: 26.132

3.  Epidemiological dynamics and associated risk factors of S. haematobium in humans and its snail vectors in Nigeria: a meta-analysis (1983-2018).

Authors:  Paul Olalekan Odeniran; Kehinde Foluke Omolabi; Isaiah Oluwafemi Ademola
Journal:  Pathog Glob Health       Date:  2020-03-17       Impact factor: 2.894

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.